Proton sponge → tert-butyl ({4-[2-(1-azetidin-3-yl-1H-pyrazol-5-yl)-4-chlorophenoxy]-3-cyanophenyl}sulfonyl)1,3-thiazol-4-ylcarbamate

HRID 46352

Reaktionsgleichung

Reaktionsgleichung von HRID 46352
[Cl:1][C:2]1[CH:32]=[CH:31][C:5]([O:6][C:7]2[CH:12]=[CH:11][C:10]([S:13]([N:16]([C:24]3[N:25]=[CH:26][S:27][CH:28]=3)[C:17](=[O:23])[O:18][C:19]([CH3:22])([CH3:21])[CH3:20])(=[O:15])=[O:14])=[CH:9][C:8]=2[C:29]#[N:30])=[C:4]([C:33]2[N:37]([CH:38]3[CH2:41][N:40](C(C4C=CC=CC=4)C4C=CC=CC=4)[CH2:39]3)[N:36]=[CH:35][CH:34]=2)[CH:3]=1.CN(C)C1C2C(=CC=CC=2N(C)C)C=CC=1.ClC(OC(Cl)C)=O>ClCCl>[NH:40]1[CH2:39][CH:38]([N:37]2[C:33]([C:4]3[CH:3]=[C:2]([Cl:1])[CH:32]=[CH:31][C:5]=3[O:6][C:7]3[CH:12]=[CH:11][C:10]([S:13]([N:16]([C:24]4[N:25]=[CH:26][S:27][CH:28]=4)[C:17](=[O:23])[O:18][C:19]([CH3:22])([CH3:20])[CH3:21])(=[O:15])=[O:14])=[CH:9][C:8]=3[C:29]#[N:30])=[CH:34][CH:35]=[N:36]2)[CH2:41]1

Komponenten

5

Versuchsvorschrift

tert-butyl {[4-(4-chloro-2-{1-[1-(diphenylmethyl)azetidin-3-yl]-1H-pyrazol-5-yl}phenoxy)-3-cyanophenyl]sulfonyl}1,3-thiazol-4-ylcarbamate, (Preparation 680, 224 mg, 0.287 mmol) was dissolved in dichloromethane (10 ml) and N,N,N′,N′-tetramethylnaphthalene-1,8-diamine (150 mg, 0.70 mmol) was added, followed by 1-chloroethyl chloroformate (0.07 ml, 0.65 mmol) and the solution was stirred at room temperature for 3.5 hours. Concentrated in vacuo and the residue was dissolved in methanol (10 ml) and refluxed for 4 hours. Concentrated in vacuo to give the crude title compound as a brown gum, 200 mg. This material was used without purification in Example 815.

Aufarbeitung

  1. concentrationConcentrated in vacuo
  2. dissolutionthe residue was dissolved in methanol (10 ml)
  3. temperaturerefluxed for 4 hours
  4. concentrationConcentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-e1f1e777542a4ca98bf16d7fa4e9f797
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08541588B2

Verknüpfte Notizen

Wird geladen…